Researchers sought to examine neurologic care spatial access disparities among various demographics of the US population.

Researchers assessed the impact of seizures in patients with dementia on clinical and mortality outcomes.

Researchers aimed to evaluate the clinical efficacy of virtual reality as a behavioral modification tool for teaching and supporting the social and communication needs of children with autism.

In a retrospective, cross-sectional study, researchers assessed whether structural changes in the amygdala occur during the earliest stages of Alzheimer disease.

In a case-control study, researchers assessed whether objective gait abnormality would be a cost-effective screening tool for posterior circulation stroke.

Researchers sought to identify associations of traumatic brain injury history and subsequent diagnosis of multiple sclerosis among post-9/11 era veterans.

Researchers sought to assess the efficacy, safety, and tolerability of ubrogepant 100 mg when administered during the prodrome of a migraine attack.

Researchers aimed to identify the national geographic patterns of Parkinson disease and test for nationwide and region-specific associations with PM2.5.

Researchers sought to estimate the associations between traumatic brain injury, mild cognitive impairment, all-cause dementia, and Alzheimer disease dementia.

Researchers sought to determine the role of antibodies and innate immune responses in the pathogenesis of neurologic post-acute sequelae of SARS-CoV-2.

In a retrospective study, researchers investigated disparities along racial/ethnic lines related to the use of medications for managing dementia in an outpatient setting.

Researchers sought to assess the effect of assisted reproductive technologies on relapse risk among women with multiple sclerosis receiving treatment with disease-modifying immunomodulatory treatment.

Study authors evaluated whether donanemab was superior to aducanumab on the percentage of participants with amyloid plaque clearance after 6 months of therapy in patients with early symptomatic AD.

Study authors conducted a global, open-label, phase 3 study to report the safety and efficacy of ravulizumab in patients with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4+ NMOSD).

Researchers sought to assess the impact of cognitive symptoms on risk for mortality from COVID-19 in people with HIV.

In a clinical trial, researchers evaluated the efficacy and safety of remote electrical neuromodulation used every other day for migraine prevention.

Researchers sought to assess the long-term effect of ofatumumab (OMB) on sNfL levels and NEDA-3 in patients with relapsing MS who receive continuous OMB and those who converted from teriflunomide in ASCLEPIOS I/II and ALITHIOS.

Researchers described the efficacy and safety results from the placebo-controlled phase of Study 041 on ataluren and change in ambulatory function in patients with Duchenne muscular dystrophy.

A study was conducted to determine the relationship between diagnosis-to-ablation time and recurrence of atrial fibrillation following ablation.

A study was conducted to determine the effect of increased cardiovascular disease screening and education for Black women in the United States.

In a study presented at ACTRIMS Forum 2023, researchers assessed pregnancy outcomes and disease activity following cladribine exposure in women with MS.

Researchers sought to evaluate the demographics and clinical presentation of patients with MOGAD-related optic neuritis in a Canadian population.

In a study presented at ACTRIMS Forum 2023, researchers assessed the efficacy of treatment regimens on disability outcomes of patients with NMOSD- and MOGAD-optic neuritis and myelitis.

In a study presented at ACTRIMS Forum 2023, researchers assessed the influence of drivers on clinician considerations when choosing S1P receptor modulators to treat patients with MS.

Researchers assessed the extent to which MS rehabilitation trials considered race and ethnicity in trial and intervention processes.

In a study presented at ACTRIMS Forum 2023, researchers identified MRI volumetric biomarkers associated with concurrent disability progression in MS.

In a study presented at ACTRIMS Forum 2023, researchers assessed the relationship between global and cortex-specific structures with cognitive performance in older patients with MS.

Researchers assessed the efficacy, safety, and tolerability of glatiramer acetate (GA) Depot when given every 4 weeks in patients with relapsing forms of MS.

Researchers sought to determine the effect of long-term depletion of CD19+ B cells on childhood vaccine-generated humoral responses in participants from N-Momentum.

Researchers sought to segment and detect active and nonactive white matter MS lesions via the development of a deep learning technique.